5G-PEARL: Paxalisib in Malignant Brain Tumours

Clinical trial NCT07391215 · RECRUITING

Trial details

NCT number: NCT07391215
Sponsor: Institute of Cancer Research, United Kingdom
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Primary Gliomas Glioblastoma Multiforme (GBM)

Start date: 2026-01-19
Primary completion: 2029-01-19
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.